Cargando…
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit...
Autores principales: | Zhang, Qian-Qian, Ding, Yi, Lei, Yan, Qi, Cui-Ling, He, Xiao-Dong, Lan, Tian, Li, Jiang-Chao, Gong, Ping, Yang, Xuesong, Geng, Jian-Guo, Wang, Li-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979993/ https://www.ncbi.nlm.nih.gov/pubmed/24719558 http://dx.doi.org/10.7150/ijbs.7723 |
Ejemplares similares
-
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
por: Zhang, Qian-Qian, et al.
Publicado: (2020) -
Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Publicado: (2021) -
Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways
por: Lin, Liteng, et al.
Publicado: (2018) -
Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway
por: Li, Junchen, et al.
Publicado: (2021) -
Andrographolide Suppresses Proliferation of Nasopharyngeal Carcinoma Cells via Attenuating NF-κB Pathway
por: Peng, Tao, et al.
Publicado: (2015)